Literature DB >> 2659314

Metabolic effects of acarbose in young healthy men.

C Couet1, M Ulmer, M Hamdaoui, H M Bau, G Debry.   

Abstract

To explore the long-term metabolic effects of acarbose in man, 6 healthy men (25 +/- 2 years; BMI: 21.6 +/- 2.7) were fed a controlled diet in a metabolic ward for 7 consecutive weeks. After an initial 3-week period to ensure a metabolic steady-state, they received 300 mg/d of acarbose (100 mg before each meal) for the remaining 4 weeks. Stool and urine collections were made over 7 d on weeks 3 and 7. Faecal excretion of water, nitrogen, carbohydrate, fat, zinc, magnesium, copper, chromium, iron, calcium and phosphorus and urinary excretion of nitrogen, urea and calcium were measured. In addition, fasting and postprandial blood glucose and insulin levels, as well as fasting triglycerides, total cholesterol, apolipoproteins (Apo) A-I, A-II, and B, zinc and copper, vitamins A, B1, B2, B6, C, and E concentrations were measured before and at the end of the acarbose period. Weight, food consumption, and water balance were not modified by acarbose. Faecal nitrogen excretion increased significantly but the nitrogen balance remained positive. Faecal excretion of carbohydrate, fat, iron and chromium were significantly increased by acarbose. Apos A-I and A-II decreased significantly. Plasma levels of vitamin B6 increased and vitamin A concentrations decreased with acarbose. This study provides new insights into the metabolic effects of acarbose with respect to nitrogen, mineral and vitamin metabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659314

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

1.  Acarbose treatment in obesity: a controlled study.

Authors:  F Bayraktar; F Hamulu; A G Ozgen; C Yilmaz; M Tüzün; T Kabalak
Journal:  Eat Weight Disord       Date:  1998-03       Impact factor: 4.652

Review 2.  Preventing long term complications. Implications for combination therapy with acarbose.

Authors:  B R Zimmerman
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 3.  A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.

Authors:  F Santeusanio; P Compagnucci
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 4.  Safety profile of acarbose, an alpha-glucosidase inhibitor.

Authors:  P Hollander
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 5.  Host-related factors explaining interindividual variability of carotenoid bioavailability and tissue concentrations in humans.

Authors:  Torsten Bohn; Charles Desmarchelier; Lars O Dragsted; Charlotte S Nielsen; Wilhelm Stahl; Ralph Rühl; Jaap Keijer; Patrick Borel
Journal:  Mol Nutr Food Res       Date:  2017-02-27       Impact factor: 5.914

6.  Iron: an underrated factor in aging.

Authors:  Dennis Mangan
Journal:  Aging (Albany NY)       Date:  2021-10-06       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.